Most Recent
Pharmaceutical company Generic Health has told the Federal Court that, on advice from their solicitors, Otsuka and Bristol-Myers Squibb "deliberately" chose not to disclose their reasons for an admission in a long-running patent case over the anti-psychotic drug Abilify, which they are now seeking to withdraw.
Otsuka Pharmaceuticals and Bristol Myers-Squibb are seeking to withdraw admissions in patent litigation against Generic Health over anti-psychotic drug Abilify, following a landmark ruling last year against Wyeth that clarified the issue of compensation under the usual undertaking for damages in pharmaceutical patent cases.
US biotechnology company ICOS has settled a dispute with Australian-based Arrow Pharma over the patents for erectile dysfunction drug Cialis, less than 12 months after a court upheld the validity of the patents in a separate case.
IP Australia has ordered biotech firm MacroGenics to amend its patent for a type of polypeptide used in treatments for cancer, autoimmune disorders and other diseases after a successful opposition from the chairman of intellectual property boutique Wrays.
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly "inconsistent" pleadings.
Industrial filter manufacturer Vokes will launch a cross claim against rival Laminar Air Flow, arguing a 17-year old error which led to six of its trade marks being revoked can still be undone.
A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.
Industrial filter manufacturer Vokes has lost its fight to correct a 17-year-old error that removed it as the registered owner of six trade marks, with the Full Federal Court ruling Monday that the Registrar did not have the power to fix the mistake of her own initiative.
Triclops Technologies has filed an appeal less than one month after the Federal Court dismissed its case alleging a rival infringed its patent for an industrial machine safety system that uses laser fields to detect hazards, but found the patent was valid.
A technology company has won dismissal of a Federal Court case alleging its industrial machine safety system that uses laser beams to detect hazards infringed on a patent licensed to a rival.